Ocular Complications From Cancer Therapy - Patient Registry and Biobank

Inclusion Criteria for the Cancer Therapy Group:

• Adult patients (greater than 18 years of age)
• Deny a history of eye diseases (excluding cataract, glaucoma, mild dry eye disease, or history of cataract or refractive surgery)
• Patients who have a history of allogenic HSCT with all stem cell sources including bone marrow, PBSC, cord AND/OR patients with a history of prior cancer therapy including BMT, chemotherapy, and immunotherapy
• Patients will be recruited after their HSCT or cancer therapy at their ophthalmology appointment
• Patients can be included with a history of prior cancer therapy including chemotherapy, BMT, immunotherapy. Prior cancer therapy must be identified and documented.
• The patient must be able to understand and sign and date the informed consent form approved by the IRB.

Inclusion Criteria for the Control Group

• No history of cancer or cancer therapy in the past
• Adult patients (greater than 18 years of age)
• Deny a history of eye diseases (excluding cataract, glaucoma, mild dry eye disease, or history of cataract or refractive surgery)
• The patient must be able to understand and sign and date the informed consent form approved by the IRB.

Exclusion Criteria for the Cancer Therapy Group:

• Vulnerable populations: neonates, children, prisoners, institutionalized individuals
• Inability or refusal to provide informed consent.
• History of ocular surgery or ocular disease (except refractive or cataract surgery, mild dry eye disease, or glaucoma).

Exclusion Criteria for the Control Group

• Vulnerable populations: neonates, children, prisoners, institutionalized individuals
• Inability or refusal to provide informed consent.
• History of ocular surgery or ocular disease (except refractive or cataract surgery, mild dry eye disease, or glaucoma).
• History of cancer or cancer therapy including chemotherapy, immunotherapy, BMT.